Meilleur Technologies Inc Announces Use of the NextGeneration Amyloid PET Imaging Biomarker NAV4694 in the NIAsponsored CLARiTI Trial

KNOXVILLE, Tenn. — Meilleur Technologies, Inc. today announced a research collaboration agreement with the National Institute of Aging (NIA)-sponsored multicenter study called the Consortium for Clarity in ADRD Research Through Imaging (CLARiTI). The collaboration will involve the network of Alzheimer’s Disease Research Centers across the country (currently, there are 37…Read More